Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease. - Suppr | 超能文献

相似文献

1

Efficacy of intermediate-dose cytarabine in central nervous system-relapsed wild-type BRAF Erdheim-Chester disease.

Ann Hematol. 2018 Jan;97(1):185-187. doi: 10.1007/s00277-017-3114-7. Epub 2017 Aug 23.

2

Langerhans cell histiocytosis and Erdheim-Chester disease overlap syndrome with bone marrow involvement and type 2 diabetes mellitus.朗格汉斯细胞组织细胞增多症与厄尔德海姆-切斯特病重叠综合征伴骨髓受累及2型糖尿病。

Ann Hematol. 2018 Jan;97(1):189-192. doi: 10.1007/s00277-017-3126-3. Epub 2017 Sep 9.

3

Efficacy of the MEK inhibitor cobimetinib for wild-type BRAF Erdheim-Chester disease.MEK抑制剂考比替尼治疗野生型BRAF Erdheim-Chester病的疗效。

Br J Haematol. 2018 Jan;180(1):150-153. doi: 10.1111/bjh.14284. Epub 2016 Oct 6.

4

Advances in Understanding and Management of Erdheim-Chester Disease.埃勒-狄克森-切斯特病的研究进展与治疗管理。

Life Sci. 2024 Jul 1;348:122692. doi: 10.1016/j.lfs.2024.122692. Epub 2024 May 6.

5

Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.接受长期大剂量干扰素-α治疗的 Erdheim-Chester 病患者的临床和正电子发射断层扫描应答反应。

Orphanet J Rare Dis. 2019 Jan 10;14(1):11. doi: 10.1186/s13023-018-0988-y.

6

Erdheim-Chester disease.骨嗜酸性肉芽肿。

Rheum Dis Clin North Am. 2013 May;39(2):299-311. doi: 10.1016/j.rdc.2013.02.011. Epub 2013 Mar 14.

7

Hypoalphalipoproteinemia and BRAF Mutation Are Major Predictors of Aortic Infiltration in the Erdheim-Chester Disease.低α脂蛋白血症和 BRAF 突变是 Erdheim-Chester 病主动脉浸润的主要预测因子。

Arterioscler Thromb Vasc Biol. 2018 Aug;38(8):1913-1925. doi: 10.1161/ATVBAHA.118.310803.

8

Erdheim-Chester disease harboring the BRAF V600E mutation.携带BRAF V600E突变的 Erdheim-Chester 病。

J Clin Oncol. 2012 Nov 10;30(32):e331-2. doi: 10.1200/JCO.2012.43.2260. Epub 2012 Sep 24.

9

Effective High-dose Interferon-α Therapy in a 13-Year-Old Girl With Erdheim-Chester Disease.13岁患有 Erdheim-Chester 病女孩的有效高剂量干扰素-α 治疗

J Pediatr Hematol Oncol. 2020 May;42(4):326-331. doi: 10.1097/MPH.0000000000001538.

10

[Erdheim-Chester disease].[ Erdheim-切斯特病]

Harefuah. 2014 Jul;153(7):389-91, 434, 433.

引用本文的文献

1

[Mutation pedigree and treatment selection of Erdheim-Chester disease].[ Erdheim-Chester病的突变谱系与治疗选择 ]

Zhonghua Xue Ye Xue Za Zhi. 2023 Oct 14;44(10):876-880. doi: 10.3760/cma.j.issn.0253-2727.2023.10.019.

2

Intermediate-dose cytarabine is an effective therapy for adults with non-Langerhans cell histiocytosis.中剂量阿糖胞苷是治疗非朗格汉斯细胞组织细胞增生症成人患者的有效方法。

Orphanet J Rare Dis. 2022 Feb 7;17(1):39. doi: 10.1186/s13023-022-02193-0.

3

[Erdheim-Chester Disease presenting with exophthalmos, impaired vision, and retroperitoneal fibrosis: a case report and literature review].